Literature DB >> 11365993

FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.

L Highleyman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11365993

Source DB:  PubMed          Journal:  BETA        ISSN: 1058-708X


× No keyword cloud information.
  10 in total

Review 1.  Antisense oligonucleotide therapy in diabetic retinopathy.

Authors:  Peter Hnik; David S Boyer; Lisa R Grillone; John G Clement; Scott P Henry; Ellen A Green
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

2.  Anti-tumour effects of transcatheter arterial embolisation administered in combination with thalidomide in a rabbit VX2 liver tumour model.

Authors:  A Nitta-Seko; N Nitta; A Sonoda; H Otani; K Tsuchiya; S Ohta; M Takahashi; K Murata
Journal:  Br J Radiol       Date:  2010-10-19       Impact factor: 3.039

3.  Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair.

Authors:  Alayna E Loiselle; Kiminori Yukata; Michael B Geary; Sirish Kondabolu; Shanshan Shi; Jennifer H Jonason; Hani A Awad; Regis J O'Keefe
Journal:  J Orthop Res       Date:  2015-06       Impact factor: 3.494

4.  Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma.

Authors:  Yi Hu; Huimin Liu; Chuanfeng Fang; Chen Li; Fjorela Xhyliu; Hayley Dysert; Juraj Bodo; Gabriel Habermehl; Benjamin E Russell; Wenjun Li; Marcia Chappell; Xiaofeng Jiang; Sarah L Ondrejka; Eric D Hsi; Jaroslaw P Maciejewski; Qing Yi; Kenneth C Anderson; Nikhil C Munshi; Geyou Ao; Jason N Valent; Jianhong Lin; Jianjun Zhao
Journal:  Cancer Res       Date:  2020-03-19       Impact factor: 12.701

5.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

6.  Thalidomide results in diminished ovarian reserve in reproductive age female IBD patients.

Authors:  Xiang Peng; Min Zhi; Ming Wei; Ting-Ting Li; Min Zhang; Yuan-Qi Zhang; Huan He; Mingli Su; Wei Wang; Jun-Rong Chen; Jian Tang; Xiang Gao; Pin-Jin Hu; Xiao-Yan Liang
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

7.  Further Studies on Cationic Gemini Amphiphiles as Carriers for Gene Delivery-The Effect of Linkers in the Structure and Other Factors Affecting the Transfection Efficacy of These Amphiphiles.

Authors:  Mange Ram Yadav; Mukesh Kumar; Prashant R Murumkar
Journal:  ACS Omega       Date:  2021-12-01

8.  AON-mediated Exon Skipping Restores Ciliation in Fibroblasts Harboring the Common Leber Congenital Amaurosis CEP290 Mutation.

Authors:  Xavier Gerard; Isabelle Perrault; Sylvain Hanein; Eduardo Silva; Karine Bigot; Sabine Defoort-Delhemmes; Marlèene Rio; Arnold Munnich; Daniel Scherman; Josseline Kaplan; Antoine Kichler; Jean-Michel Rozet
Journal:  Mol Ther Nucleic Acids       Date:  2012-06-26       Impact factor: 10.183

9.  Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.

Authors:  Yi Hu; Jianhong Lin; Hua Fang; Jing Fang; Chen Li; Wei Chen; Shuang Liu; Sarah Ondrejka; Zihua Gong; Frederic Reu; Jaroslaw Maciejewski; Qing Yi; Jian-Jun Zhao
Journal:  Leukemia       Date:  2018-03-22       Impact factor: 11.528

10.  The Analogs of Furanyl Methylidene Rhodanine Exhibit Broad-Spectrum Inhibitory and Inactivating Activities against Enveloped Viruses, including SARS-CoV-2 and Its Variants.

Authors:  Jing Pu; Xiaoyang He; Wei Xu; Cong Wang; Qiaoshuai Lan; Chen Hua; Kai Wang; Lu Lu; Shibo Jiang
Journal:  Viruses       Date:  2022-02-27       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.